A novel protein has been discovered that could be a useful blood-based biomarker to monitor the progression of inherited Alzheimer’s disease, over a decade before the clinical symptoms appear.
Browsing: Alzheimer’s disease
Researchers have identified the DAG peptide as a potential biomarker for Alzheimer’s disease development.
The newly designed polygenic hazard score test could allow earlier diagnoses and more successful intervention strategies for Alzheimer’s disease.
Researchers have identified new biomarkers that could aid stage-specific diagnosis of Alzheimer’s, leading to advancements in treatment.
Research funded by the Alzheimer’s society shows potential for the development of a blood test to detect biomarkers as a predictor of Alzheimer’s disease.
European researchers have developed a faster and more affordable method to identify individuals more susceptible to Alzheimer’s disease utilizing a biochip-based blood test.
Researchers have developed a biosensor with nanometric sensitivity that is able to detect peptides linked to neurodegenerative disorders such as Alzheimer’s and Parkinson’s.
Mid-life biomarker changes could predict chances of developing Alzheimer’s disease.
Studying the metabolic profiles of different brain regions could help us better understand neurodegenerative diseases.
Scientists have discovered that a skin test could offer new information on Alzheimer’s and Parkinson’s disease.